Logo image of TSE

TRINSEO PLC (TSE) Stock Fundamental Analysis

NYSE:TSE - New York Stock Exchange, Inc. - IE0000QBK8U7 - Common Stock - Currency: USD

2.63  +0.07 (+2.73%)

After market: 2.63 0 (0%)

Fundamental Rating

2

TSE gets a fundamental rating of 2 out of 10. The analysis compared the fundamentals against 85 industry peers in the Chemicals industry. Both the profitability and financial health of TSE have multiple concerns. TSE is valued expensive and it does not seem to be growing.


Dividend Valuation Growth Profitability Health

1

1. Profitability

1.1 Basic Checks

In the past year TSE has reported negative net income.
TSE had a negative operating cash flow in the past year.
In multiple years TSE reported negative net income over the last 5 years.
TSE had a positive operating cash flow in 4 of the past 5 years.
TSE Yearly Net Income VS EBIT VS OCF VS FCFTSE Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M -200M 400M -400M -600M

1.2 Ratios

TSE's Return On Assets of -13.26% is on the low side compared to the rest of the industry. TSE is outperformed by 76.47% of its industry peers.
Industry RankSector Rank
ROA -13.26%
ROE N/A
ROIC N/A
ROA(3y)-15.93%
ROA(5y)-7.64%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
TSE Yearly ROA, ROE, ROICTSE Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 100 -100 200

1.3 Margins

In the last couple of years the Operating Margin of TSE has declined.
TSE has a worse Gross Margin (7.92%) than 84.71% of its industry peers.
In the last couple of years the Gross Margin of TSE has declined.
The Profit Margin and Operating Margin are not available for TSE so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 7.92%
OM growth 3Y-72.52%
OM growth 5Y-32.82%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-19.47%
GM growth 5Y-3.22%
TSE Yearly Profit, Operating, Gross MarginsTSE Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10 -10

1

2. Health

2.1 Basic Checks

TSE does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for TSE has been increased compared to 1 year ago.
TSE has less shares outstanding than it did 5 years ago.
The debt/assets ratio for TSE is higher compared to a year ago.
TSE Yearly Shares OutstandingTSE Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M 40M
TSE Yearly Total Debt VS Total AssetsTSE Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 1B 2B 3B 4B

2.2 Solvency

Based on the Altman-Z score of 0.97, we must say that TSE is in the distress zone and has some risk of bankruptcy.
The Altman-Z score of TSE (0.97) is worse than 78.82% of its industry peers.
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Altman-Z 0.97
ROIC/WACCN/A
WACC7.06%
TSE Yearly LT Debt VS Equity VS FCFTSE Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 500M -500M 1B 1.5B 2B

2.3 Liquidity

TSE has a Current Ratio of 1.50. This is a normal value and indicates that TSE is financially healthy and should not expect problems in meeting its short term obligations.
The Current ratio of TSE (1.50) is worse than 65.88% of its industry peers.
TSE has a Quick Ratio of 1.50. This is a bad value and indicates that TSE is not financially healthy enough and could expect problems in meeting its short term obligations.
With a Quick ratio value of 0.95, TSE is not doing good in the industry: 65.88% of the companies in the same industry are doing better.
Industry RankSector Rank
Current Ratio 1.5
Quick Ratio 0.95
TSE Yearly Current Assets VS Current LiabilitesTSE Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B

3

3. Growth

3.1 Past

TSE shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 9.64%, which is quite good.
The Revenue has decreased by -5.28% in the past year.
TSE shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 0.81% yearly.
EPS 1Y (TTM)9.64%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%29.38%
Revenue 1Y (TTM)-5.28%
Revenue growth 3Y-10.05%
Revenue growth 5Y0.81%
Sales Q2Q%-13.19%

3.2 Future

TSE is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 18.68% yearly.
The Revenue is expected to grow by 0.82% on average over the next years.
EPS Next Y21.95%
EPS Next 2Y22.7%
EPS Next 3Y18.68%
EPS Next 5YN/A
Revenue Next Year-3.59%
Revenue Next 2Y0.32%
Revenue Next 3Y0.82%
Revenue Next 5YN/A

3.3 Evolution

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is stable.
TSE Yearly Revenue VS EstimatesTSE Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 1B 2B 3B 4B 5B
TSE Yearly EPS VS EstimatesTSE Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 0 5 -5 10

1

4. Valuation

4.1 Price/Earnings Ratio

TSE reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Also next year TSE is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
TSE Price Earnings VS Forward Price EarningsTSE Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 20 30

4.2 Price Multiples

The rest of the industry has a similar Enterprise Value to EBITDA ratio as TSE.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 13.42
TSE Per share dataTSE EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 20 -20 40 60 80

4.3 Compensation for Growth

A more expensive valuation may be justified as TSE's earnings are expected to grow with 18.68% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y22.7%
EPS Next 3Y18.68%

2

5. Dividend

5.1 Amount

TSE has a Yearly Dividend Yield of 1.50%. Purely for dividend investing, there may be better candidates out there.
Compared to an average industry Dividend Yield of 3.75, TSE has a dividend in line with its industry peers.
Compared to the average S&P500 Dividend Yield of 2.40, TSE is paying slightly less dividend.
Industry RankSector Rank
Dividend Yield 1.5%

5.2 History

The dividend of TSE decreases each year by -50.57%.
TSE has paid a dividend for at least 10 years, which is a reliable track record.
Dividend Growth(5Y)-50.57%
Div Incr Years0
Div Non Decr Years0
TSE Yearly Dividends per shareTSE Yearly Dividends per shareYearly Dividends per share 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0.5 1 1.5

5.3 Sustainability

The earnings of TSE are negative and hence is the payout ratio. TSE will probably not be able to sustain this dividend level.
DP-0.45%
EPS Next 2Y22.7%
EPS Next 3Y18.68%
TSE Yearly Income VS Free CF VS DividendTSE Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M -200M 400M -400M -600M

TRINSEO PLC

NYSE:TSE (8/4/2025, 8:04:00 PM)

After market: 2.63 0 (0%)

2.63

+0.07 (+2.73%)

Chartmill FA Rating
GICS SectorMaterials
GICS IndustryGroupMaterials
GICS IndustryChemicals
Earnings (Last)05-07 2025-05-07/amc
Earnings (Next)08-06 2025-08-06/amc
Inst Owners71.35%
Inst Owner Change-0.36%
Ins Owners5.5%
Ins Owner Change29.01%
Market Cap93.76M
Analysts49.09
Price Target4.21 (60.08%)
Short Float %8.1%
Short Ratio6.67
Dividend
Industry RankSector Rank
Dividend Yield 1.5%
Yearly Dividend0.05
Dividend Growth(5Y)-50.57%
DP-0.45%
Div Incr Years0
Div Non Decr Years0
Ex-Date07-10 2025-07-10 (0.01)
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-7.45%
Min EPS beat(2)-15.89%
Max EPS beat(2)0.99%
EPS beat(4)1
Avg EPS beat(4)-9.86%
Min EPS beat(4)-15.89%
Max EPS beat(4)0.99%
EPS beat(8)2
Avg EPS beat(8)-68.87%
EPS beat(12)2
Avg EPS beat(12)-54.58%
EPS beat(16)4
Avg EPS beat(16)-41.48%
Revenue beat(2)0
Avg Revenue beat(2)-7.71%
Min Revenue beat(2)-14.85%
Max Revenue beat(2)-0.57%
Revenue beat(4)0
Avg Revenue beat(4)-5.6%
Min Revenue beat(4)-14.85%
Max Revenue beat(4)-0.57%
Revenue beat(8)1
Avg Revenue beat(8)-5.51%
Revenue beat(12)1
Avg Revenue beat(12)-5.88%
Revenue beat(16)3
Avg Revenue beat(16)-4.16%
PT rev (1m)0%
PT rev (3m)-25%
EPS NQ rev (1m)-11.84%
EPS NQ rev (3m)-17.82%
EPS NY rev (1m)-2.68%
EPS NY rev (3m)-30.39%
Revenue NQ rev (1m)-3.03%
Revenue NQ rev (3m)-9.07%
Revenue NY rev (1m)-3.24%
Revenue NY rev (3m)-6.79%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.03
P/FCF N/A
P/OCF N/A
P/B N/A
P/tB N/A
EV/EBITDA 13.42
EPS(TTM)-7.12
EYN/A
EPS(NY)-3.8
Fwd EYN/A
FCF(TTM)-3.21
FCFYN/A
OCF(TTM)-1.63
OCFYN/A
SpS95.2
BVpS-19.05
TBVpS-37.15
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -13.26%
ROE N/A
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 7.92%
FCFM N/A
ROA(3y)-15.93%
ROA(5y)-7.64%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3Y-72.52%
OM growth 5Y-32.82%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-19.47%
GM growth 5Y-3.22%
F-Score4
Asset Turnover1.28
Health
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Debt/EBITDA 12.76
Cap/Depr 27.98%
Cap/Sales 1.66%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.5
Quick Ratio 0.95
Altman-Z 0.97
F-Score4
WACC7.06%
ROIC/WACCN/A
Cap/Depr(3y)41.39%
Cap/Depr(5y)51.15%
Cap/Sales(3y)2.23%
Cap/Sales(5y)2.42%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)9.64%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%29.38%
EPS Next Y21.95%
EPS Next 2Y22.7%
EPS Next 3Y18.68%
EPS Next 5YN/A
Revenue 1Y (TTM)-5.28%
Revenue growth 3Y-10.05%
Revenue growth 5Y0.81%
Sales Q2Q%-13.19%
Revenue Next Year-3.59%
Revenue Next 2Y0.32%
Revenue Next 3Y0.82%
Revenue Next 5YN/A
EBIT growth 1Y77.12%
EBIT growth 3Y-75.28%
EBIT growth 5Y-32.27%
EBIT Next Year793.49%
EBIT Next 3Y136.74%
EBIT Next 5YN/A
FCF growth 1Y-119.35%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-161.98%
OCF growth 3YN/A
OCF growth 5YN/A